Literature DB >> 14707094

Expression of signaling lymphocytic activation molecule-associated protein interrupts IFN-gamma production in human tuberculosis.

Virginia Pasquinelli1, María F Quiroga, Gustavo J Martínez, Liliana Castro Zorrilla, Rosa M Musella, María M Bracco, Liliana Belmonte, Alejandro Malbrán, Leonardo Fainboim, Peter A Sieling, Verónica E García.   

Abstract

Production of the Th1 cytokine IFN-gamma by T cells is considered crucial for immunity against Mycobacterium tuberculosis infection. We evaluated IFN-gamma production in tuberculosis in the context of signaling molecules known to regulate Th1 cytokines. Two populations of patients who have active tuberculosis were identified, based on their T cell responses to the bacterium. High responder tuberculosis patients displayed significant M. tuberculosis-dependent T cell proliferation and IFN-gamma production, whereas low responder tuberculosis patients displayed weak or no T cell responses to M. tuberculosis. The expression of the signaling lymphocytic activation molecule (SLAM)-associated protein (SAP) on cells from tuberculosis patients was inversely correlated with IFN-gamma production in those individuals. Moreover, patients with a nonfunctional SAP gene displayed immune responses to M. tuberculosis similar to those of high responder tuberculosis patients. In contrast to SAP, T cell expression of SLAM was directly correlated with responsiveness to M. tuberculosis Ag. Our data suggest that expression of SAP interferes with Th1 responses whereas SLAM expression contributes to Th1 cytokine responses in tuberculosis. The study further suggests that SAP and SLAM might be focal points for therapeutic modulation of T cell cytokine responses in tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14707094     DOI: 10.4049/jimmunol.172.2.1177

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

1.  HIV-1 infection ex vivo accelerates measles virus infection by upregulating signaling lymphocytic activation molecule (SLAM) in CD4+ T cells.

Authors:  Yu-ya Mitsuki; Kazutaka Terahara; Kentaro Shibusawa; Takuya Yamamoto; Takatsugu Tsuchiya; Fuminori Mizukoshi; Masayuki Ishige; Seiji Okada; Kazuo Kobayashi; Yuko Morikawa; Tetsuo Nakayama; Makoto Takeda; Yusuke Yanagi; Yasuko Tsunetsugu-Yokota
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

2.  The impact of IFN-γ receptor on SLPI expression in active tuberculosis: association with disease severity.

Authors:  Nancy L Tateosian; Virginia Pasquinelli; Rodrigo E Hernández Del Pino; Nella Ambrosi; Diego Guerrieri; Sigifredo Pedraza-Sánchez; Natalia Santucci; Luciano D'Attilio; Joaquín Pellegrini; María A Araujo-Solis; Rosa M Musella; Domingo J Palmero; Rogelio Hernandez-Pando; Verónica E Garcia; H Eduardo Chuluyan
Journal:  Am J Pathol       Date:  2014-03-04       Impact factor: 4.307

3.  IL17A augments autophagy in Mycobacterium tuberculosis-infected monocytes from patients with active tuberculosis in association with the severity of the disease.

Authors:  Nancy Liliana Tateosian; Joaquín Miguel Pellegrini; Nicolás Oscar Amiano; Agustín Rolandelli; Nicolás Casco; Domingo Juan Palmero; María Isabel Colombo; Verónica Edith García
Journal:  Autophagy       Date:  2017-06-05       Impact factor: 16.016

4.  IFNG-mediated immune responses enhance autophagy against Mycobacterium tuberculosis antigens in patients with active tuberculosis.

Authors:  Ana I Rovetta; Delfina Peña; Rodrigo E Hernández Del Pino; Gabriela M Recalde; Joaquín Pellegrini; Fabiana Bigi; Rosa M Musella; Domingo J Palmero; Marisa Gutierrez; María I Colombo; Verónica E García
Journal:  Autophagy       Date:  2014       Impact factor: 16.016

5.  IL-17 and IFN-γ expression in lymphocytes from patients with active tuberculosis correlates with the severity of the disease.

Authors:  Javier O Jurado; Virginia Pasquinelli; Ivana B Alvarez; Delfina Peña; Ana I Rovetta; Nancy L Tateosian; Horacio E Romeo; Rosa M Musella; Domingo Palmero; H Eduardo Chuluyán; Verónica E García
Journal:  J Leukoc Biol       Date:  2012-03-13       Impact factor: 4.962

6.  Phosphorylation of mitogen-activated protein kinases contributes to interferon γ production in response to Mycobacterium tuberculosis.

Authors:  Virginia Pasquinelli; Ana I Rovetta; Ivana B Alvarez; Javier O Jurado; Rosa M Musella; Domingo J Palmero; Alejandro Malbrán; Buka Samten; Peter F Barnes; Verónica E García
Journal:  J Infect Dis       Date:  2012-11-02       Impact factor: 5.226

7.  IFN-gamma production during active tuberculosis is regulated by mechanisms that involve IL-17, SLAM, and CREB.

Authors:  Virginia Pasquinelli; James C Townsend; Javier O Jurado; Ivana B Alvarez; María F Quiroga; Peter F Barnes; Buka Samten; Verónica E García
Journal:  J Infect Dis       Date:  2009-03-01       Impact factor: 5.226

8.  CD137 differentially regulates innate and adaptive immunity against Mycobacterium tuberculosis.

Authors:  Darío A Fernández Do Porto; Javier O Jurado; Virginia Pasquinelli; Ivana B Alvarez; Romina H Aspera; Rosa M Musella; Verónica E García
Journal:  Immunol Cell Biol       Date:  2011-07-12       Impact factor: 5.126

9.  ICOS, SLAM and PD-1 expression and regulation on T lymphocytes reflect the immune dysregulation in patients with HIV-related illness with pulmonary tuberculosis.

Authors:  Javier Oscar Jurado; Virginia Pasquinelli; Ivana Belén Alvarez; Gustavo Javier Martínez; Natalia Laufer; Omar Sued; Pedro Cahn; Rosa María Musella; Eduardo Abbate; Horacio Salomón; María Florencia Quiroga
Journal:  J Int AIDS Soc       Date:  2012-06-14       Impact factor: 5.396

10.  Neutrophil autophagy during human active tuberculosis is modulated by SLAMF1.

Authors:  Joaquín Miguel Pellegrini; Florencia Sabbione; María Paula Morelli; Nancy Liliana Tateosian; Florencia Andrea Castello; Nicolás Oscar Amiano; Domingo Palmero; Alberto Levi; Lorena Ciallella; María Isabel Colombo; Analía Silvina Trevani; Verónica Edith García
Journal:  Autophagy       Date:  2020-10-04       Impact factor: 16.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.